FOXD1 and melanoma: Abnormal FOXD1 expression is involved in the progression of tumors [11] including breast cancer [12], colorectal cancer, melanoma, glioma [13], osteosarcoma, renal cell carcinoma, ovarian carcinoma, medulloblastoma [14], and lung cancer [15].